Charles River Laboratories International (CRL) Income from Discontinued Operations (2010 - 2011)

Charles River Laboratories International (CRL) posted quarterly Income from Discontinued Operations of 42000.0 for Q3 2011, up 111.41% year-over-year from 19866.32 in Q3 2010, and up 103.45% quarter-over-quarter from 1219000.0 in Q2 2011.

Charles River Laboratories International (CRL) Income from Discontinued Operations (2010 - 2011) Analysis & Trends

Charles River Laboratories International's Income from Discontinued Operations history runs 2 years deep, the most recent figure standing at 42000.0 for Q3 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Thermo Fisher Scientific 213.77 Bn 209.71 Bn 8.34 Bn -
2 Danaher 139.78 Bn 135.43 Bn 3.61 Bn -
3 Idexx Laboratories 46.04 Bn 45.85 Bn 779.09 Mn -
4 Agilent Technologies 39.68 Bn 37.88 Bn 990.00 Mn -
5 Iqvia Holdings 39.34 Bn 37.26 Bn 1.44 Bn -
6 Natera 38.75 Bn 37.65 Bn 696.04 Mn -
7 Illumina 29.90 Bn 28.73 Bn 770.00 Mn -
8 Mettler Toledo International 28.58 Bn 28.53 Bn 650.22 Mn -
9 Quest Diagnostics 26.18 Bn 25.55 Bn 1.03 Bn -
10 Charles River Laboratories International 12.69 Bn 12.47 Bn 1.81 Bn -

Historic Data

Download Data
DateValue
Sep 24, 2011 42,000.00
Jun 25, 2011 -1.22 Mn
Mar 26, 2011 -11.11 Mn
Sep 25, 2010 -368,000.00
Jun 26, 2010 -640,000.00